Pathologic complete response rates in triple-negative, HER2-positive, and hormone receptor-positive breast cancers after anthracycline-free neoadjuvant chemotherapy with carboplatin and paclitaxel with or without trastuzumab

BACKGROUND: Pathologic complete response (pCR) to neoadjuvant chemotherapy (NCT) in the breast and lymph nodes in patients with locally advanced or inflammatory breast cancer (LABC) is associated with improved disease-free and overall survival. Increasingly, studies are testing the efficacy of plati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast
Main Authors: Shinde, Arvind M., Zhai, Jing, Yu, Kim Wai, Frankel, Paul, Yim, John H., Luu, Thehang, Kruper, Laura, Vito, Courtney, Shaw, Sally, Vora, Nayana L., Kirschenbaum, Michele, Somlo, George
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4596816/
https://ncbi.nlm.nih.gov/pubmed/25467313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2014.10.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados